{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:42:12Z","timestamp":1785469332178,"version":"3.56.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Rett syndrome (RTT, MIM #312750) is a rare genetic disorder that leads to developmental regression and severe disability and is caused by pathogenic variants in the <jats:italic>MECP2<\/jats:italic> gene. The diagnosis of RTT is based on clinical features and, depending on resources and access, on molecular confirmation. There is scarce information on molecular diagnosis from patients in Latin America, mostly due to limited availability and coverage of genomic testing. This pilot study aimed to implement genomic testing and characterize clinical and molecular findings in a group of Chilean patients with a clinical diagnosis of RTT.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Twenty-eight patients with suspected RTT underwent characterization of phenotypic manifestations and molecular testing using Clinical Exome Solution<jats:sup>TM<\/jats:sup> CES_V2 by SOPHiA Genetics. Data was analyzed using the commercial bioinformatics platform, SOPHiA DDM<jats:sup>TM<\/jats:sup>. A virtual panel of 34 genes, including <jats:italic>MECP2<\/jats:italic> and other genes that are in the differential diagnosis of RTT, was used to prioritize initial analyses, followed by evaluation of the complete exome sequence data.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Twelve patients (42.8% of participants) had variants in <jats:italic>MECP2<\/jats:italic>, of which 11 (39.2%) were interpreted as pathogenic\/likely pathogenic (P\/LP), thus confirming the diagnosis of RTT in them. Eight additional patients (28.5%) harbored ten variants in nine other genes. Four of these variants were interpreted as P\/LP (14.2%) (<jats:italic>GRIN2B, MADD, TRPM3<\/jats:italic> and <jats:italic>ZEB2<\/jats:italic>) resulting in alternative neurodevelopmental diagnoses, and six were considered of uncertain significance. No evident candidate variant was found for eight patients.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> This study allowed to reach a diagnosis in half of the participants. The diagnosis of RTT was confirmed in over a third of them, while others were found to have alternative neurodevelopmental disorders. Further evaluation is needed to identify the cause in those with negative or uncertain results. This information is useful for the patients, families, and clinicians to guide clinical management, even more so since the development of novel therapies for RTT. We also show the feasibility of implementing a step-wide approach to genomic testing in a setting with limited resources.<\/jats:p>","DOI":"10.3389\/fgene.2024.1278198","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T04:39:11Z","timestamp":1710736751000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Genomic analysis in Chilean patients with suspected Rett syndrome: keep a broad differential diagnosis"],"prefix":"10.3389","volume":"15","author":[{"given":"Florencia","family":"Brito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Lagos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Cubillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Orellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallen","family":"Gajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"B\u00f6hme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Encina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela M.","family":"Repetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1750-1172-9-87","article-title":"Twenty years of surveillance in Rett syndrome: what does this tell us?","volume":"9","author":"Anderson","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1136\/jmg.2006.041467","article-title":"CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients","volume":"43","author":"Archer","year":"2006","journal-title":"J. Med. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ajhg.2008.05.015","article-title":"FOXG1 is responsible for the congenital variant of Rett syndrome","volume":"83","author":"Ariani","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.32641\/rchped.v90i2.724","article-title":"Rett Syndrome: MECP2 gene molecular analysis in Chilean patients","volume":"90","author":"Aron","year":"2019","journal-title":"Rev. Chil. Pediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.3390\/ijms20153621","article-title":"Pathogenic variants in STXBP1 and in genes for GABAa receptor subunities cause atypical Rett\/Rett-like phenotypes","volume":"20","author":"Cogliati","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41431-020-0624-x","article-title":"High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot","volume":"28","author":"Croci","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13023-019-1261-8","article-title":"Rare diseases in Chile: challenges and recommendations in universal health coverage context","volume":"14","author":"Encina","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"620859","DOI":"10.3389\/fgene.2021.620859","article-title":"MeCP2: the genetic driver of Rett syndrome epigenetics","volume":"12","author":"Good","year":"2021","journal-title":"Front. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1111\/j.1528-1167.2012.03656.x","article-title":"Epilepsy in Rett syndrome, and CDKL5\u2010 and FOXG1\u2010gene\u2013related encephalopathies","volume":"53","author":"Guerrini","year":"2012","journal-title":"Epilepsia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of Rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jama.2023.4003","article-title":"Trofinetide receives FDA approval as first drug for Rett syndrome","volume":"329","author":"Harris","year":"2023","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/jmedgenet-2018-105775","article-title":"Genetic landscape of Rett syndrome-like phenotypes revealed by whole exome sequencing","volume":"56","author":"Iwama","year":"2019","journal-title":"J. Med. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1212\/01.wnl.0000223318.28938.45","article-title":"Early progressive encephalopathy in boys and MECP2 mutations","volume":"67","author":"Kankirawatana","year":"2006","journal-title":"Neurology"},{"key":"B14","volume-title":"MECP2 disorders","author":"Kaur","year":"1993"},{"key":"B15","doi-asserted-by":"publisher","first-page":"D1207","DOI":"10.1093\/nar\/gkaa1043","article-title":"The human phenotype Ontology in 2021","volume":"49","author":"K\u00f6hler","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/humu.23263","article-title":"RettBASE: Rett syndrome database update","volume":"38","author":"Krishnaraj","year":"2017","journal-title":"Hum. Mutat."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11689-020-09332-3","article-title":"A small-molecule screen reveals novel modulators of MeCP2 and X-chromosome inactivation maintenance","volume":"12","author":"Lee","year":"2020","journal-title":"J. Neurodev. Disord."},{"key":"B19","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1016\/s0387-7604(01)00339-4","article-title":"Spectrum of MECP2 mutations in Rett syndrome","volume":"23","author":"Lee","year":"2001","journal-title":"Brain Dev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1590\/s0004-282x2009000400001","article-title":"Genotype-phenotype correlation in Brazillian Rett syndrome patients","volume":"67","author":"Lima","year":"2009","journal-title":"Arq. Neuropsiquiatr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/jmedgenet-2015-103568","article-title":"Identification of novel genetic causes of Rett syndrome-like phenotypes","volume":"53","author":"Lopes","year":"2016","journal-title":"J. Med. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00439-016-1721-3","article-title":"Whole exome sequencing of Rett syndrome-like patients reveals the mutational diversity of the clinical phenotype","volume":"135","author":"Lucariello","year":"2016","journal-title":"Hum. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41436-021-01242-6","article-title":"Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"2021","author":"Manickam","year":"2021","journal-title":"Genet. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/jmg.2009.067884","article-title":"Novel FOXG1 mutations associated with the congenital variant of Rett syndrome","volume":"47","author":"Mencarelli","year":"2010","journal-title":"J. Med. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","article-title":"Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome","volume":"70","author":"Neul","year":"2008","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"106704","DOI":"10.1016\/j.cct.2022.106704","article-title":"Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome","volume":"114","author":"Neul","year":"2022","journal-title":"Contemp. Clin. Trials"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/ajmg.a.37132","article-title":"Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome","volume":"167","author":"Olson","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1172805","DOI":"10.3389\/fnins.2023.1172805","article-title":"Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives","volume":"17","author":"Palmieri","year":"2023","journal-title":"Front. Neurosci."},{"key":"B30","unstructured":"Capacity for genomic sequencing grows in Latin America and Caribbean with training and equipment provided by PAHO - PAHO\/WHO2022"},{"key":"B31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/jmg.2009.067355","article-title":"Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females","volume":"47","author":"Philippe","year":"2010","journal-title":"J. Med. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/nejmsr1406261","article-title":"ClinGen \u2014 the clinical genome resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B33","first-page":"723","article-title":"On a unusual brain atrophy syndrome in hyperammonemia in childhood","volume":"116","author":"Rett","year":"1966","journal-title":"Wien Med. Wochenschr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/ajmg.a.32606","article-title":"A novel CDKL5 mutation in a 47,XXY boy with the early\u2010onset seizure variant of Rett syndrome","author":"Sartori","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"B36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/jmg.2004.026237","article-title":"CDKL5\/STK9 is mutated in Rett syndrome variant with infantile spasms","volume":"42","author":"Scala","year":"2005","journal-title":"J. Med. Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/cge.13153","article-title":"Clinician\u2019s guide to genes associated with Rett\u2010like phenotypes\u2014Investigation of a Danish cohort and review of the literature","volume":"95","author":"Sch\u00f6newolf-Greulich","year":"2019","journal-title":"Clin. Genet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","article-title":"The missing diversity in human genetic studies","volume":"177","author":"Sirugo","year":"2019","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1079601","DOI":"10.3389\/fpubh.2023.1079601","article-title":"Undiagnosed diseases: needs and opportunities in 20 countries participating in the undiagnosed diseases network international","volume":"11","author":"Taruscio","year":"2023","journal-title":"Front. Public Health"},{"key":"B40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000479291","article-title":"Cancer genomic resources and present needs in the Latin American region","volume":"20","author":"Torres","year":"2017","journal-title":"Public Health Genomics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"12288","DOI":"10.1038\/s41598-017-11620-3","article-title":"The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome","volume":"7","author":"Vidal","year":"2017","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ejpn.2019.04.006","article-title":"The most recurrent monogenic disorders that overlap with the phenotype of Rett syndrome","volume":"23","author":"Vidal","year":"","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e793","DOI":"10.1002\/mgg3.793","article-title":"Characterization of large deletions of the MECP2 gene in Rett syndrome patients by gene dosage analysis","volume":"7","author":"Vidal","year":"","journal-title":"Mol. Genet. Genomic Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.3390\/ijms20163925","article-title":"Genetic landscape of Rett syndrome spectrum: improvements and challenges","volume":"20","author":"Vidal","year":"","journal-title":"Int. J. Mol. Sci."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1278198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T04:39:15Z","timestamp":1710736755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1278198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":44,"alternative-id":["10.3389\/fgene.2024.1278198"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2024.1278198","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]},"article-number":"1278198"}}